Brian Ritchie
LifeSci Advisors
Replay available
Relmada Therapeutics, Inc. (RLMD) Q2 2025 Earnings Call
Relmada Therapeutics, Inc. (NASDAQ: RLMD) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Magid Shenouda
Chief Financial Officer
Dr. Raj Pruthi
Chief Medical Officer, Oncology
Dr. Sergio Traversa
Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Relmada Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.157 Good afternoon, and welcome to the Roll Mata Therapeutics second quarter 2025 earnings 00:00:05.157 -- 00:00:10.083 conference call. At this time, all participants are in a listen-only mode. 00:00:10.083 -- 00:00:13.407 After the prepared remarks, we will conduct a question and answer session. 00:00:13.407 -- 00:00:18.793 To ask a question, please press star 1. As a reminder, this conference 00:00:18.793 -- 00:00:23.699 call is being recorded and will be available for replay on the Roll Mata website. 00:00:23.699 -- 00:00:27.323 I would now like to turn the call over to Brian Ritchie from LifeSci Advisors. 00:00:27.323 -- 00:00:30.044 Please go ahead, Mr. Ritchie. 00:00:30.338 -- 00:00:34.844 Thank you. Good day, everyone, and thank you for joining us today. 00:00:34.844 -- 00:00:40.312 This afternoon, Ramada issued a press release providing a business update and outlining 00:00:40.312 -- 00:00:45.757 its financial results for the three months ended June 30, 2025. 00:00:46.000 -- 00:00:51.127 Please note that certain information discussed on the call today is covered under 00:00:51.127 -- 00:00:56.134 the safe harbor provision of the Private Securities Litigation Reform Act. 00:00:56.134 -- 00:01:01.596 We caution listeners that during this call, Ramada's management team will be making forward-looking 00:01:01.596 -- 00:01:06.843 statements. Actual results could differ materially from those stated or implied 00:01:06.843 -- 00:01:11.610 by these forward-looking statements due to risks and uncertainties associated with the 00:01:11.610 -- 00:01:16.276 company's business. These forward-looking statements are qualified by the cautionary 00:01:16.276 -- 00:01:21.544 statements contained in Ramada's press release issued today and the co...